Guilty verdict is handed down in 2012 MOMS Pharmacy drug-diversion case
‘Operation Black Market Meds’ involved New York State, Florida and federal investigators
PPD snaps up Evidera, deepening services in real-world evidence
CROs are expanding their scope of services
Ocean transportation for life sciences: More reliable, more cost-effective
Advanced engineering brings powered, active control of temperature-sensitive shipments via ocean containers
Generics distributor Anda, Inc. has a new owner: Teva Pharma
Deal deepens Teva’s business in generics
A 30% capacity expansion at Sharp Packaging
Company invests $45 million for serialization- and cold-chain-ready capacity
New Zika virus test—and a map of ‘Zika zones’
While CDC steps up its analysis, private companies race to commercialize tests, vaccines and tracking mechanisms
Private-capital injection into inVentiv Health reshuffles life sciences outsourcing
Advent joins Thomas Lee Partners in ownership of the clinical, commercial outsourcer
A fake drugs intrusion in the US—with a twist
Painkiller addicts buy street drugs that simulate well-known pharma brands
Pharma company runs afoul of child-resistant packaging rules
Consumer Products Safety Commission steps into distribution of a generic form of Ambien
Take a survey--help the industry understand cold chain trends
Cold Chain Technologies looks into shipping practices
UPS steps into clinical trial materials management
Emphasis is on cold chain capabilities, dedicated global network
A jurisdictional battle breaks out over physician assistant certification
AAPA is positioning itself to provide alternative certification
Preparing for a cell culturing industry
GE Healthcare makes a key acquisition in cell culture production technology
They don’t call them ‘vaults’ for nothing
WDSrx expands controlled substances storage
Sonoco ThermoSafe launches 3-Day and 5-Day shipping solutions
New ZERO Bench-Time® Shippers optimize inventory, provide lowest total cost of ownership
Home infusion patient satisfaction to be studied
Powering up medical affairs
Technology is enabling more resources to reach the medical affairs teams—in a compliant manner
Biopharma is an active user of consulting services, whose revenue is up 10.5%
Technology projects, M&A and reimbursement questions drive growth
Enough already with REMS abuse in generic drug development
3PLs set specialty pharmaceutical markets in motion
Managing the physical movement of specialty drugs calls for dedicated services
In the track-and-trace trenches
As the pharma industry moves ahead with traceability initiatives, vendors are building their capabilities
Consider enterprise quality management systems for GDP tasks
The growing compliance requirements for distribution call for a streamlined approach
Changing of the guard at PDMA Alliance
FDA provides more guidances for compounding pharmacies; HHS worries about volume growth
New guidance restricts some compounding to other than “essentially copies” of approved products
When it Comes to Compliance, Learning Never Stops
Cardiovascular therapy: More new drugs for a growing patient base
The scale of the cardiovascular market pushes payers to demand quality outcomes data
Battle fronts in the illicit online pharmacy war
The annual Operation Pangea nets a next crop of crooks; consumer groups raise awareness
A conversation with Terry Hisey, Deloitte
The keys to a successful and impactful partnership: A case study
Dealing with biologics production uncertainty
The biologics development and approval process for pharmaceutical companies around the world is typically long and complex, which increases the risk of inaccurately forecasting demand
